1. Home
  2. BBAR vs PTGX Comparison

BBAR vs PTGX Comparison

Compare BBAR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBAR

Banco BBVA Argentina S.A. ADS

N/A

Current Price

$12.41

Market Cap

2.7B

Sector

Finance

ML Signal

N/A

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

N/A

Current Price

$139.40

Market Cap

9.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBAR
PTGX
Founded
1886
2006
Country
Argentina
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
9.3B
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
BBAR
PTGX
Price
$12.41
$139.40
Analyst Decision
Buy
Strong Buy
Analyst Count
4
13
Target Price
$25.00
★ $174.69
AVG Volume (30 Days)
472.4K
★ 535.2K
Earning Date
08-27-2026
11-05-2026
Dividend Yield
★ 3.00%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 2.35
Revenue
N/A
N/A
Revenue This Year
$55.59
$1,078.44
Revenue Next Year
$18.23
N/A
P/E Ratio
★ $26.78
$60.03
Revenue Growth
N/A
N/A
52 Week Low
$7.85
$62.24
52 Week High
$22.47
$160.81

Technical Indicators

Market Signals
Indicator
BBAR
PTGX
Relative Strength Index (RSI) 28.19 44.31
Support Level $12.62 $132.37
Resistance Level $17.05 $142.20
Average True Range (ATR) 0.46 4.59
MACD -0.10 -0.44
Stochastic Oscillator 8.94 39.61

Price Performance

Historical Comparison
BBAR
PTGX

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: